LPA and familial hyperaldosteronism: Premature ASCVD risk conferred by excessive exposure to LDL-C in patients with FH is further accentuated by elevated Lp(a) levels and this appears to be independent of the type of FH mutation (Alonso et al., 2014; Vuorio et al., 2020).